119 related articles for article (PubMed ID: 7590773)
21. Highly efficient gene delivery for bladder cancers by intravesically administered replication-competent retroviral vectors.
Kikuchi E; Menendez S; Ozu C; Ohori M; Cordon-Cardo C; Logg CR; Kasahara N; Bochner BH
Clin Cancer Res; 2007 Aug; 13(15 Pt 1):4511-8. PubMed ID: 17671137
[TBL] [Abstract][Full Text] [Related]
22. Adenovirus-mediated tumor suppressor p53 gene therapy for anaplastic thyroid carcinoma in vitro and in vivo.
Nagayama Y; Yokoi H; Takeda K; Hasegawa M; Nishihara E; Namba H; Yamashita S; Niwa M
J Clin Endocrinol Metab; 2000 Nov; 85(11):4081-6. PubMed ID: 11095436
[TBL] [Abstract][Full Text] [Related]
23. Adenovirus-mediated p53 gene transfer inhibits growth of human tumor cells expressing mutant p53 protein.
Harris MP; Sutjipto S; Wills KN; Hancock W; Cornell D; Johnson DE; Gregory RJ; Shepard HM; Maneval DC
Cancer Gene Ther; 1996; 3(2):121-30. PubMed ID: 8729911
[TBL] [Abstract][Full Text] [Related]
24. [Adenovirus-mediated p53 gene therapy of human laryngeal cancer].
Wang Q; Han D; Wang W
Zhonghua Zhong Liu Za Zhi; 1998 Nov; 20(6):418-21. PubMed ID: 10920932
[TBL] [Abstract][Full Text] [Related]
25. Stable expression of the wild-type p53 gene in human lung cancer cells after retrovirus-mediated gene transfer.
Cai DW; Mukhopadhyay T; Liu Y; Fujiwara T; Roth JA
Hum Gene Ther; 1993 Oct; 4(5):617-24. PubMed ID: 8280799
[TBL] [Abstract][Full Text] [Related]
26. Stable transgene expression in tumors and metastases after transduction with lentiviral vectors based on human immunodeficiency virus type 1.
Bao L; Jaligam V; Zhang XY; Kutner RH; Kantrow SP; Reiser J
Hum Gene Ther; 2004 May; 15(5):445-56. PubMed ID: 15144575
[TBL] [Abstract][Full Text] [Related]
27. Development and characterization of recombinant adenoviruses encoding human p53 for gene therapy of cancer.
Wills KN; Maneval DC; Menzel P; Harris MP; Sutjipto S; Vaillancourt MT; Huang WM; Johnson DE; Anderson SC; Wen SF
Hum Gene Ther; 1994 Sep; 5(9):1079-88. PubMed ID: 7833367
[TBL] [Abstract][Full Text] [Related]
28. Gene therapy for primary and metastatic pancreatic cancer with intraperitoneal retroviral vector bearing the wild-type p53 gene.
Hwang RF; Gordon EM; Anderson WF; Parekh D
Surgery; 1998 Aug; 124(2):143-50; discussion 150-1. PubMed ID: 9706132
[TBL] [Abstract][Full Text] [Related]
29. p53 gene transfer does not enhance E2F-1-mediated apoptosis in human colon cancer cells.
Draus JM; Elliott MJ; Atienza C; Stilwell A; Wong SL; Dong Y; Yang H; McMasters KM
Exp Mol Med; 2001 Dec; 33(4):209-19. PubMed ID: 11795482
[TBL] [Abstract][Full Text] [Related]
30. Restoration of p53 function in anaplastic Wilms' tumor.
Delatte SJ; Hazen-Martin DJ; Re GG; Kelly JR; Sutphin A; Tagge EP
J Pediatr Surg; 2001 Jan; 36(1):43-50. PubMed ID: 11150436
[TBL] [Abstract][Full Text] [Related]
31. In vivo expression and antitumor activity of p53 gene transfer with naked plasmid DNA in an ovarian cancer xenograft model in nude mice.
Collinet P; Vereecque R; Sabban F; Vinatier D; Leblanc E; Narducci F; Querleu D; Quesnel B
J Obstet Gynaecol Res; 2006 Oct; 32(5):449-53. PubMed ID: 16984510
[TBL] [Abstract][Full Text] [Related]
32. Tumor-suppressive effect of adenovirus-mediated inhibitor of growth 4 gene transfer in breast carcinoma cells in vitro and in vivo.
Li Z; Xie Y; Sheng W; Miao J; Xiang J; Yang J
Cancer Biother Radiopharm; 2010 Aug; 25(4):427-37. PubMed ID: 20707719
[TBL] [Abstract][Full Text] [Related]
33. [Construction of the wt-p53 gene recombinant retroviral vector. Inhibiting the growth of laryngocarcinoma cell line].
Chen X; Cao K; Liu D; Wang Z; Liang C
Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 1996 Aug; 18(4):252-6. PubMed ID: 9388972
[TBL] [Abstract][Full Text] [Related]
34. Mutations in p53 cDNA sequence introduced by retroviral vector.
Su S; Watanabe A; Yamamoto M; Nakajima E; Miyake K; Shimada T
Biochem Biophys Res Commun; 2006 Feb; 340(2):567-72. PubMed ID: 16380088
[TBL] [Abstract][Full Text] [Related]
35. Potentials and limitations of adenovirus-p53 gene therapy for brain tumors.
Hong YK; Joe YA; Yang YJ; Lee KS; Son BC; Jeun SS; Chung DS; Cho KK; Park CK; Kim MC; Kim HK; Yung WK; Kang JK
J Korean Med Sci; 2000 Jun; 15(3):315-22. PubMed ID: 10895975
[TBL] [Abstract][Full Text] [Related]
36. In vitro and in vivo antisense-mediated growth inhibition of a mammary adenocarcinoma from MMTV-neu transgenic mice.
Sacco MG; Barbieri O; Piccini D; Noviello E; Zoppé M; Zucchi I; Frattini A; Villa A; Vezzoni P
Gene Ther; 1998 Mar; 5(3):388-93. PubMed ID: 9614559
[TBL] [Abstract][Full Text] [Related]
37. Comparisons of tumor suppressor p53, p21, and p16 gene therapy effects on glioblastoma tumorigenicity in situ.
Wang TJ; Huang MS; Hong CY; Tse V; Silverberg GD; Hsiao M
Biochem Biophys Res Commun; 2001 Sep; 287(1):173-80. PubMed ID: 11549271
[TBL] [Abstract][Full Text] [Related]
38. [Recombinant virus-mediated transfer of the wild-type p53 gene is a potent therapeutic strategy for human cancer].
Fujiwara T; Kagawa S; Ogawa N; Yasuda T; Tanaka N; Orita K; Cai DW; Zhang WW; Roth JA
Hum Cell; 1996 Mar; 9(1):25-30. PubMed ID: 9183626
[TBL] [Abstract][Full Text] [Related]
39. Intracerebral adenovirus-mediated p53 tumor suppressor gene therapy for experimental human glioma.
Li H; Alonso-Vanegas M; Colicos MA; Jung SS; Lochmuller H; Sadikot AF; Snipes GJ; Seth P; Karpati G; Nalbantoglu J
Clin Cancer Res; 1999 Mar; 5(3):637-42. PubMed ID: 10100717
[TBL] [Abstract][Full Text] [Related]
40. The effect of wild type P53 gene transfer on growth properties and tumorigenicity of PANC-1 tumor cell line.
Hagi-Sharifia Taghavi M; Davoodi J; Mirshahi M
Iran Biomed J; 2007 Jan; 11(1):1-6. PubMed ID: 18051698
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]